Correlation Between Mountain High and THC Therapeutics

Can any of the company-specific risk be diversified away by investing in both Mountain High and THC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mountain High and THC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mountain High Acquisitions and THC Therapeutics, you can compare the effects of market volatilities on Mountain High and THC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mountain High with a short position of THC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mountain High and THC Therapeutics.

Diversification Opportunities for Mountain High and THC Therapeutics

0.0

Correlation Coefficient

Mountain High  THC Therapeutics

Pay attention - limited upside

The 3 months correlation between Mountain and THC is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mountain High Acquisitions and THC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on THC Therapeutics and Mountain High is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mountain High Acquisitions are associated (or correlated) with THC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of THC Therapeutics has no effect on the direction of Mountain High i.e., Mountain High and THC Therapeutics go up and down completely randomly.

Pair Corralation between Mountain High and THC Therapeutics

Given the investment horizon of 90 days Mountain High Acquisitions is expected to under-perform the THC Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Mountain High Acquisitions is 11.0 times less risky than THC Therapeutics. The pink sheet trades about -0.08 of its potential returns per unit of risk. The THC Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  6.00  in THC Therapeutics on September 12, 2024 and sell it today you would lose (5.93) from holding THC Therapeutics or give up 98.83% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	29.29%
Values	Daily Returns

Mountain High Acquisitions  vs.  THC Therapeutics

Mountain High Acquis

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mountain High Acquisitions has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical indicators, Mountain High is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

THC Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in THC Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, THC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mountain High and THC Therapeutics

The main advantage of trading using opposite Mountain High and THC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mountain High position performs unexpectedly, THC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in THC Therapeutics will offset losses from the drop in THC Therapeutics' long position.

The idea behind Mountain High Acquisitions and THC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.